Financials
Financial year 2025
PHARMACAR from Merelbeke-Melle, company number BE0449954393, closed financial year 2025 with a result of € 311,180 after tax. For that financial year PHARMACAR recorded a gross margin of € 510,874 and equity of € 2 million. Compared with financial year 2024, the result moved from € 506,619 to € 311,180. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 30, 2026.
€ 2 million
▼ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 311,180
▼ 39% vs 2024
Profit after tax over the fiscal year.
€ 551,704
▼ 3% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 324,062 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
€ 34,395
▼ 35% vs 2024
Of which on lease € 31,203.
Debts at end 2025
€ 28,111
▼ 36% vs 2024
€ 14,812 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 471,143
▲ € 400,755 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 20,063
▼ 74% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 414,733 | € 420,099 | € 789,492 | € 510,874 | ▼ 35% |
| Profit after taxes | € 209,549 | € 236,742 | € 506,619 | € 311,180 | ▼ 39% |
| Equity | € 1,633,159 | € 1,813,318 | € 2,049,495 | € 2,036,613 | ▼ 1% |
| Total debts | € 565,230 | € 337,934 | € 194,192 | € 528,237 | ▲ 172% |
| Cash | € 289,684 | € 564,711 | € 566,249 | € 551,704 | ▼ 3% |
| Retained profit | € 1,534,559 | € 1,714,718 | € 1,950,895 | € 1,938,013 | ▼ 1% |
| Dividend | € 1,600 | € 56,582 | € 270,442 | € 324,062 | ▲ 20% |
| Bank debt | € 95,761 | € 51,713 | € 43,764 | € 28,111 | ▼ 36% |
| Balance sheet total | € 2,198,389 | € 2,151,253 | € 2,243,687 | € 2,564,850 | ▲ 14% |
| Employees (FTE) | 1 | 0 | 0 | 0 |
Key figures of PHARMACAR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to PHARMACAR?
What happened at PHARMACAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 311,180 (▼ 39% vs 2024). Source: NBB ↗
- Axel Dejonghe became a director. NBB
- New establishment in Merelbeke-Melle. KBO
- Hilde Noterdame became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 209,549 profit in 2022 to € 311,180 profit in 2025.
Paid € 560,102 in corporate taxes since 2022.
Best year ever: 2024, with € 506,619 profit.
On average € 414,700 of value added per employee in 2022.
A new publication or filing at PHARMACAR? We notify you, reason included.
Follow PHARMACARDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMACAR are Axel Dejonghe and Hilde Noterdame.
Directors
According to the 2025 annual accounts
Axel Dejonghe
Director
since 2005
Hilde Noterdame
Director
since 1993
Establishments
Establishment units
Physical locations of this company
Burg. Maenhautstraat 59
9820 Merelbeke-Melle
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0449.954.393
- VAT number
- BE 0449.954.393
- Registered office
- Burg. Maenhautstraat 59, 9820 Merelbeke-Melle
- Names & denominations
- PHARMACAR
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 23 April 1993
- Peppol
- Active · Active since 1 Sept 2025
- Activities · NACE
Groothandel in delen en toebehoren van motorvoertuigen
Groothandel in onderdelen en accessoires van auto's
Handelsbemiddeling en groothandel in onderdelen en accessoires van motorvoertuigen